Document Detail


Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study.
MedLine Citation:
PMID:  20951231     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Right ventricular apex pacing for gradient reduction in hypertrophic obstructive cardiomyopathy (HOCM) with severe left ventricular (LV) obstruction has yielded conflicting results.
OBJECTIVE: The purpose of this study was to assess the feasibility and effectiveness of biventricular pacing in HOCM.
METHODS: Transvenous biventricular pacing was attempted in 12 severely symptomatic HOCM patients. Optimal intervals were programmed after implant. Echocardiographic LV pressure gradient and synchrony were assessed. LV lead implantation was successful in 9 patients. Optimal pacing mode was biventricular in 6 patients, left ventricular only in 2 patients, and right ventricular only in 1 patient.
RESULTS: Functional capacity and quality of life progressively improved. New York Heart Association functional class decreased from 3.2 ± 0.4 at baseline to 1.9 ± 0.3 at 3 months and to 1.4 ± 0.5 at 1 year (P <.05); 6-minute walk test increased from 349 ± 116 m at baseline to 454 ± 144 m at 3 months and to 517 ± 206 m (P <.05); and quality of life increased from 54 ± 16 points at baseline to 28 ± 13 points at 3 months and 27 ± 15 points at 1 year (P <.05). There was also a progressive reduction in LV gradient from 74 ± 23 mmHg at baseline to 50 ± 27 mmHg acutely, 40 ± 26 mmHg at 3 months, and 28 ± 17 mmHg at 1 year (P <.05). Gradient reduction was associated with diminished peak longitudinal displacement of the LV septum and earlier displacement of the lateral wall. A progressive reduction of LV mass was observed, from 356 ± 110 g at baseline to 315 ± 70 g at 3 months (P = .13) and to 284 ± 42 g at 1 year (P <.05).
CONCLUSION: Biventricular pacing is feasible and usually the best configuration for gradient reduction in HOCM. Biventricular pacing reduces LV hypertrophy.
Authors:
Antonio Berruezo; Radu Vatasescu; Lluis Mont; Marta Sitges; Diego Perez; Giorgi Papiashvili; Giorgi Papiashvilli; Barbara Vidal; Antonio Francino; Juan Fernández-Armenta; Etelvino Silva; Bart Bijnens; Jose Ramón González-Juanatey; Josep Brugada
Publication Detail:
Type:  Journal Article     Date:  2010-10-14
Journal Detail:
Title:  Heart rhythm : the official journal of the Heart Rhythm Society     Volume:  8     ISSN:  1556-3871     ISO Abbreviation:  Heart Rhythm     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-31     Completed Date:  2011-06-16     Revised Date:  2011-08-18    
Medline Journal Info:
Nlm Unique ID:  101200317     Medline TA:  Heart Rhythm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  221-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Affiliation:
Cardiology Department, Thorax Institute, Hospital Clinic, Barcelona, Spain. berruezo@clinic.ub.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cardiac Resynchronization Therapy / methods*,  mortality
Cardiomyopathy, Hypertrophic / diagnosis,  mortality,  therapy*
Chi-Square Distribution
Echocardiography, Doppler
Female
Follow-Up Studies
Humans
Male
Middle Aged
Pilot Projects
Risk Assessment
Severity of Illness Index
Statistics, Nonparametric
Survival Analysis
Time Factors
Treatment Outcome
Ventricular Remodeling / physiology*
Comments/Corrections
Comment In:
Heart Rhythm. 2011 Jul;8(7):e24; author reply e24   [PMID:  21642016 ]
Erratum In:
Heart Rhythm. 2011 Jun;8(6):953
Note: Papiashvilli, Giorgi [corrected to Papiashvili, Giorgi]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-arthritic effects of chlorogenic acid in interleukin-1?-induced rabbit chondrocytes and a rabbi...
Next Document:  A combined gene and cell therapy approach for restoration of conduction.